pecam1 af555 (Cell Signaling Technology Inc)
Cell Signaling Technology Inc is a verified supplier 
Cell Signaling Technology Inc manufactures this product 
94
Structured Review
Cell Signaling Technology Inc
pecam1 af555
Pecam1 Af555, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pecam1+af555/CD31+(PECAM-1)+Mouse+mAb/pmc13043533-113-32-36
Average 94 stars, based on 7 article reviews
Pecam1 Af555, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pecam1+af555/CD31+(PECAM-1)+Mouse+mAb/pmc13043533-113-32-36
Average 94 stars, based on 7 article reviews
pecam1 af555 - by Bioz Stars,
2026-10
94/100 stars
Images
Related Articles
Staining:Article Title: Breathing lung-on-chip: a versatile tool for assessing respiratory toxicity across multiple therapeutic modalities Article Snippet: .. Briefly, the membranes were detached using the AX Disassembly tool (AlveoliX), blocked with 2% BSA (A9418, Sigma), and stained with the following antibody dilutions in 2% BSA: ZO1-AF488 (1:100 dilution, 339,188, Invitrogen), Article Title: Breathing lung-on-chip: a versatile tool for assessing respiratory toxicity across multiple therapeutic modalities. Article Snippet: 1 Biopharma Safety, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden 2 Department of Immunotechnology, Lund University, Lund, Sweden 3 AlveoliX AG, Swiss Organs-on-Chip Innovation, Bern, Switzerland 4 Pathology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge, UK 5 Integrated Bioanalysis, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden 6 Safety Innovation, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden 7 Immune Safety, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK 8 Safety Sciences, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden Abstract Inhalation administration of therapeutics is a crucial method for treatment of respiratory diseases, offering direct access to the target organ.. However, the progression of candidate drugs is frequently impacted by clinical dose level limitations due to lung histopathological findings or functional effects identified in in vivo studies.. Addressing these safety concerns is crucial in advancing compounds with the right safety profile. |